COMP <GO>
DGX vs LH // NET PROFIT MARGIN
Quest Diagnostics Incorporated (NYSE) VS. Labcorp Holdings Inc. (NYSE) • 15-METRIC TALLY: DGX 11
— LH 2
▲ NET PROFIT MARGIN LEADER: DGX
LAST: $250.81 (-0.40%) • MKT CAP: $27.71B
net-margins
9.00%
LAST: $355.59 (-1.60%) • MKT CAP: $29.31B
net-margins
6.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DGX VS. LH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DGX | LH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.20% | 28.80% | +4.40 | DGX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.30% | 8.30% | +2.00 | DGX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.3x | 19.6x | -3.30 | DGX | /valuation <GO> |
| Free Cash Flow Yield | 4.88% | 4.04% | +0.84 | DGX | /fcf-yield <GO> |
| Operating Margin | 14.10% | 9.90% | +4.20 | DGX | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 9.00% | 6.30% | +2.70 | DGX | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | 7.20% | +4.60 | DGX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.27% | 0.81% | +0.46 | DGX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.01 | 3.58 | +0.43 | DGX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.9 | 69.5 | -2.60 | LH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.96 | +0.05 | DGX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.1x | 31.6x | -5.50 | DGX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.71B | $29.31B | -$1.60B | LH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DGX REV | LH REV | DGX GROSS % | LH GROSS % | DGX FCF | LH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.04B | $13.95B | 33.2% | 28.8% | $1.36B | $1.21B |
| FY 2024 | $9.87B | $13.01B | 32.9% | 27.9% | $909.0M | $1.10B |
| FY 2023 | $9.25B | $12.16B | — | — | $855.7M | $780.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DGX // BETA 1.01
LH // BETA 0.96